Omalizumab outcomes for up to 6 years in pediatric patients with severe persistent allergic asthma
FI: 6,377
Type: Article
Collaboration
Year: 2021
Writers
Garcia, AN; Garriga-Baraut, T; Martin, AMP; Cid, MN; Borrego, JT; Gimenez, MDF; Blasco, JL; Garcia, MB; Moreno-Galarraga, L; Tortajada-Girbes, M; Juesas, CR; Anton, MP; Caballero-Rabasco, MA; Gaboli, M; Neyra, AL; Moron, JN; Benavente, A.F.; Navarrete, LV;
Magazine
Title: PEDIATRIC ALLERGY AND IMMUNOLOGY
Quartile
- D1